ANNX
ANNX
NASDAQ · Biotechnology

Annexon Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.90
-0.04 (-0.81%)
As of Jun 21, 10:14 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +732.9% upside
Low Target $23.52
Average Target $40.81
High Target $51.70
Current Price $4.90
Current
$4.90
Target
$40.81
$23.52 $40.81 avg $51.70
Scenario Analysis
Bear Case
$23.52
380.0%
Low target
Base Case
$40.81
+732.9%
Avg target
Bull Case
$51.70
+955.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.18
-31.8% from high
52-Week Low
$1.85
+164.9% from low
Target vs 52W High
$40.81
+468.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%